AIM
Price
$0.21
Change
+$0.01 (+5.00%)
Updated
Jan 17 closing price
Capitalization
13.64M
78 days until earnings call
HOTH
Price
$1.50
Change
-$0.08 (-5.06%)
Updated
Jan 17 closing price
Capitalization
10.36M
Ad is loading...

AIM vs HOTH

Header iconAIM vs HOTH Comparison
Open Charts AIM vs HOTHBanner chart's image
AIM ImmunoTech
Price$0.21
Change+$0.01 (+5.00%)
Volume$925.53K
Capitalization13.64M
Hoth Therapeutics
Price$1.50
Change-$0.08 (-5.06%)
Volume$876.99K
Capitalization10.36M
AIM vs HOTH Comparison Chart
Loading...
AIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AIM vs. HOTH commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIM is a Hold and HOTH is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (AIM: $0.21 vs. HOTH: $1.50)
Brand notoriety: AIM and HOTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AIM: 135% vs. HOTH: 7%
Market capitalization -- AIM: $13.64M vs. HOTH: $10.36M
AIM [@Biotechnology] is valued at $13.64M. HOTH’s [@Biotechnology] market capitalization is $10.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIM’s FA Score shows that 0 FA rating(s) are green whileHOTH’s FA Score has 1 green FA rating(s).

  • AIM’s FA Score: 0 green, 5 red.
  • HOTH’s FA Score: 1 green, 4 red.
According to our system of comparison, HOTH is a better buy in the long-term than AIM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIM’s TA Score shows that 3 TA indicator(s) are bullish while HOTH’s TA Score has 6 bullish TA indicator(s).

  • AIM’s TA Score: 3 bullish, 6 bearish.
  • HOTH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, HOTH is a better buy in the short-term than AIM.

Price Growth

AIM (@Biotechnology) experienced а -0.56% price change this week, while HOTH (@Biotechnology) price change was -21.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

AIM is expected to report earnings on May 15, 2025.

HOTH is expected to report earnings on Mar 01, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AIM($13.6M) has a higher market cap than HOTH($10.4M). HOTH YTD gains are higher at: 100.508 vs. AIM (7.980). HOTH has higher annual earnings (EBITDA): -7.53M vs. AIM (-26.19M). HOTH has more cash in the bank: 8.02M vs. AIM (7.2M). HOTH has less debt than AIM: HOTH (33.8K) vs AIM (3.4M). AIM has higher revenues than HOTH: AIM (190K) vs HOTH (0).
AIMHOTHAIM / HOTH
Capitalization13.6M10.4M131%
EBITDA-26.19M-7.53M348%
Gain YTD7.980100.5088%
P/E RatioN/AN/A-
Revenue190K0-
Total Cash7.2M8.02M90%
Total Debt3.4M33.8K10,062%
FUNDAMENTALS RATINGS
AIM vs HOTH: Fundamental Ratings
AIM
HOTH
OUTLOOK RATING
1..100
8596
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
6335
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HOTH's Valuation (25) in the Pharmaceuticals Major industry is somewhat better than the same rating for AIM (58) in the null industry. This means that HOTH’s stock grew somewhat faster than AIM’s over the last 12 months.

HOTH's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as AIM (100) in the null industry. This means that HOTH’s stock grew similarly to AIM’s over the last 12 months.

HOTH's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as AIM (99) in the null industry. This means that HOTH’s stock grew similarly to AIM’s over the last 12 months.

HOTH's Price Growth Rating (35) in the Pharmaceuticals Major industry is in the same range as AIM (63) in the null industry. This means that HOTH’s stock grew similarly to AIM’s over the last 12 months.

HOTH's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as AIM (100) in the null industry. This means that HOTH’s stock grew similarly to AIM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AIMHOTH
RSI
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
74%
Momentum
ODDS (%)
Bullish Trend 11 days ago
86%
Bullish Trend 11 days ago
87%
MACD
ODDS (%)
Bullish Trend 11 days ago
74%
Bullish Trend 11 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 11 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 11 days ago
79%
Advances
ODDS (%)
Bullish Trend 13 days ago
78%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
Aroon
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Ad is loading...
AIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.850.04
+2.21%
Alto Ingredients
FBP19.670.26
+1.34%
First BanCorp
BURL290.561.12
+0.39%
Burlington Stores
SMP31.21-0.21
-0.67%
Standard Motor Products
PPBT3.54-0.18
-4.84%
Purple Biotech Ltd

AIM and

Correlation & Price change

A.I.dvisor indicates that over the last year, AIM has been loosely correlated with HOTH. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if AIM jumps, then HOTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AIM
1D Price
Change %
AIM100%
+8.42%
HOTH - AIM
33%
Loosely correlated
-5.06%
SLN - AIM
32%
Poorly correlated
+1.79%
ATAI - AIM
25%
Poorly correlated
+5.04%
VRCA - AIM
24%
Poorly correlated
+5.80%
EDSA - AIM
24%
Poorly correlated
+0.60%
More

HOTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOTH has been loosely correlated with TIL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HOTH jumps, then TIL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOTH
1D Price
Change %
HOTH100%
-5.06%
TIL - HOTH
34%
Loosely correlated
-2.10%
PPTDF - HOTH
32%
Poorly correlated
N/A
CRMD - HOTH
31%
Poorly correlated
-4.85%
AIM - HOTH
30%
Poorly correlated
+8.42%
OGEN - HOTH
28%
Poorly correlated
-5.37%
More